Home › Calculator › BOLD Dividend Calculator 2026
BOLD Dividend DRIP Calculator 2026
79.06% YieldHealthcareBoundless Bio, Inc. · NASDAQ
Price: $2.53 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When BOLD pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your BOLD snowball 📈
$10,000 in BOLD → $3.39M in 10 years · $124,676.18/month
About Boundless Bio, Inc. (BOLD) — Dividend Analysis 2026
Boundless Bio, Inc., a clinical-stage oncology company, focuses on developing innovative cancer therapies aimed at addressing the significant unmet needs of patients with oncogene amplified tumors. Their core strategy involves targeting extrachromosomal DNA (ecDNA). The company's lead product candidate, BBI-355, an orally administered inhibitor of checkpoint kinase 1 (CHK1), is currently in Phase 1/2 clinical trials for patients suffering from oncogene amplified cancers. Additionally, Boundless Bio is advancing BBI-825, another oral inhibitor, this one targeting ribonucleotide reductase (RNR), also in Phase 1/2 clinical development for cancer patients exhibiting resistance gene amplifications. A third initiative, the ecDTx 3 program, is designed to target a kinesin crucial for the cellular segregation mechanism of ecDNA. Incorporated in 2018, the company originally operated as Pretzel Therapeutics, Inc. before adopting the name Boundless Bio, Inc. in July 2019. Its headquarters are situated in San Diego, California.
Compare BOLD with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full BOLD DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open BOLD position with:
🌍 BOLD Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold BOLD.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 79.06% | 76.26% | $7,906 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 67.20% | 64.40% | $6,720 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 63.25% | 60.45% | $6,325 / yr |
| 🇬🇧 UK ISA | 0% | 79.06% | 76.26% | $7,906 / yr |
| 🇬🇧 UK Taxable | 8.75% | 72.14% | 69.34% | $7,214 / yr |
| 🇨🇦 TFSA | 0% | 79.06% | 76.26% | $7,906 / yr |
| 🇨🇦 CA Taxable | 25% | 59.30% | 56.50% | $5,930 / yr |
| 🇦🇺 Super (pension) | 15% | 67.20% | 64.40% | $6,720 / yr |
| 🇦🇺 AU Taxable | 30% | 55.34% | 52.54% | $5,534 / yr |
| 🇩🇪 DE Taxable | 26.375% | 58.21% | 55.41% | $5,821 / yr |
| 🇫🇷 FR Taxable | 30% | 55.34% | 52.54% | $5,534 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 BOLD Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 BOLD Dividend Payment Schedule
BOLD pays quarterly — 4 times per year. Next ex-div: TBD.
📊 BOLD vs Healthcare Benchmarks
How BOLD compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BOLD sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ BOLD Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2026-07-21 | 2,975 | $2.44 | $7.3K | ||
| Buy | 2026-07-20 | 1,623 | $2.44 | $4.0K | ||
| Buy | 2026-07-17 | 265 | $2.44 | $647.00 | ||
| Buy | 2026-07-16 | 18,491 | $2.44 | $45.1K | ||
| Buy | 2026-07-15 | 1,600 | $2.44 | $3.9K | ||
| Buy | 2026-07-14 | 43,878 | $2.43 | $106.6K | ||
| Buy | 2026-07-13 | 48,211 | $2.42 | $116.7K | ||
| Buy | 2026-07-10 | 43,367 | $2.43 | $105.4K | ||
| Buy | 2026-07-09 | 7 | $2.48 | $17.00 | ||
| Buy | 2026-07-08 | 14,338 | $2.46 | $35.3K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Insiders are net buyers — historically a positive signal for dividend sustainability. Last purchase: 2026-07-21
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BOLD dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Boundless Bio, Inc. (BOLD) is currently trading at $2.53, 82% below its 52-week high. The current dividend yield is 79.06% based on an annual payout of $2.00 per share.
BOLD (Boundless Bio, Inc.) — 79.06% Dividend Yield Analysis
Boundless Bio, Inc. (BOLD) is a healthcare stock currently trading at $2.53 with a dividend yield of 79.06%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (79.06%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.